Sign in

CIK 0001287098

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522210438
Phone
+1 301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
  1. 4 Grant or award Director acquired 51,679 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Director sold 47,689 shares at an average $3.75 ($178,752)
  4. 4 Planned sale Director sold 3,000 shares at $3.82 ($11,460)
  5. 4 Grant or award Chief Commercial Officer acquired 10,400 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale Director sold 47,689 shares at an average $4.02 ($191,655)
  8. 4 Planned sale Director sold 3,000 shares at $4.28 ($12,840)
  9. 4 Planned sale EVP, GLOBAL SALES sold 33,333 shares at an average $4.44 ($148,135)
  10. 4 Planned sale Director sold 3,000 shares at $4.75 ($14,238)
  11. 4 Planned sale EVP, GLOBAL SALES sold 33,333 shares at an average $4.03 ($134,366)
  12. 4 Planned sale Director sold 10,000 shares at $3.99 ($39,900)
  13. 4 Planned sale EVP, GLOBAL SALES sold 33,333 shares at $4.09 ($136,465)
  14. 4 Grant or award Director acquired 21,367 shares (grant or award)
  15. 4 Grant or award Director acquired 21,367 shares (grant or award)
  16. 4 Grant or award Director acquired 21,367 shares (grant or award)
  17. 4 Grant or award Director acquired 21,367 shares (grant or award)
  18. 4 Grant or award Director acquired 21,367 shares (grant or award)
  19. 4 Grant or award Director acquired 21,367 shares (grant or award)
  20. 4 Grant or award Director acquired 21,367 shares (grant or award)

Page 3 of 9 · 163 filings